FORM 7
MONTHLY PROGRESS REPORT

Name of CNSX Issuer: Wildflower Marijuana Inc. (the “Issuer”).

Trading Symbol: SUN

Number of Outstanding Listed Securities: 45,605,593

Date: March 1, 2017

Report on Business

  1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact.

On December 7, 2016 the Company announced it had entered into an Online Digital Media and Marketing Services Agreement with Joe Rich Project Web Media (“JRP”) to build awareness online of the Wildflower brand. The Agreement provides that JRP will assist in the development of Wildflower’s website, online ads, analytics, a messaging plan and overall marketing strategy. JRP will then oversee the implementation of the online marketing campaign and monitor its effectiveness and adjust accordingly. As consideration for the Agreement JRP will receive 120,000 common shares of Wildflower. Online marketing will be a key strategy for Wildflower going forward as all indications are that these so-called “new media” channels will continue to evolve and grow in importance. William MacLean, CEO of Wildflower states “The cost and effort of developing the right marketing strategy and properly configuring it to meet our business needs, I believe will be invaluable to Wildflower going forward. The Joe Rich team is highly accomplished and professional and we look forward to working with them.”

On November 28, 2016, the Company announced that its licensee had successfully launched the Company's new vaporizer into the Washington State recreational market. The vaporizer is presently available in two cannabidiol (“CBD”) and three tetrahydrocannabinol (“THC”) blends. Following the beta launch of the vaporizer earlier in 2016, the Company in conjunction with the licensee, has perfected various blends, conducted rigorous testing and sought consumer and industry leaders feedback. To see product reviews from two of the largest cannabis publications visit under the Products we Love (November issue) and under Product Reviews. Both the CBD and THC vaporizers have been well received and as at November 28, 2016 is available in 26 licensed retailers throughout Washington State. Retail acquisitions continue to grow. For the purpose of access to the full Wildflower product line, the Company's Washington State lincensee has successfully permitted and built out a licensed commercial kitchen through the Liquor and Cannabis Board and the Department of Agriculture. Additional Wildflower products will now be available this December for the Washington State market.

Kee joined the Company’s advisory board. Alfred is a business technology leader with over 15 years of experience in building and growing high performing teams at small startups and large enterprises. With foundations in running large scale business critical technology and a user experienced focused product management mindset, Alfred excels at guiding teams to deliver high business value with agility. Alfred’s knowledge and experience has been honed and proven atemployers and clients including KPMG, Centurylink, Cisco, and Apple as well as a string of successful startups. On top of all this, Alfred brings a global perspective having lived and worked throughout the US, Canada, Europe and Asia

On June 7, 2016 the Company announced that it has added Andy Liu to the Company’s advisory board. Andy is a Technology leader with 15 years of experience at multi nationals including Nortel, IBM, and EA as well as startups like Hootsuite Media. Although Andy specializes in the Agile development of digital media systems, Andy also brings a practical approach to tackling any problem with incremental solutions and through building high performing teams.

On February 3, 2016, the Company announced that it launched a line of products into the legal US cannabis market. The first delivery of the Company’s disposable vaporizers made their way to retail store shelves in Washington. The vaporizers have reservoirs filled with different blends, four of which were sold into the Washington market.Twoblends were high in THC content, the active ingredient in cannabis giving it its narcotic and psychoactive effect. The other two blends had higher CBD content which is a constituent in cannabis providing health benefits. The Company has an agreement with a licensed Washington State marijuana processor to purchase the Company’s technology and proprietary blends along with a license to use the Wildflower brand. This agreement currently encompasses the disposable vaporizers but both parties look to extend that agreement to other products in the Wildflower development pipeline.

On December 9, 2015, the Company announced it had entered an agreement with Biologic Nutrigenomics Research Corporation (“BNRC”) to conduct medical research on Wildflower’s products and to assist in new product development. As part of this collaboration Franco Cavaleri will be added to the Wildflower advisory board as its Scientific and Product Development Advisor. As a prominent Nutraceutical Biochemist, Mr. Cavaleri has had much success in developing products for the nutraceutical industry garnering him widespread recognition in the health industry. He has won Gold, Silver and Bronze Alive Formulation awards, an annual event put on by the Alive Publishing Group that promotes and recognizes outstanding product innovation while enhancing the credibility of natural health products. The agreement with BNRC is for a period of one year with automatic annual renewals. The Company will issue 400,000 common shares as consideration for the agreement and grant 300,000 stock options at a price of $0.20 for a period of five years. The agreement is subject to raising sufficient proceeds to fund the first year of testing, including lab space, clinical technicians and other costs. The agreement also provides that if the Company does a deal with a pharmaceutical company or another interested party based on the work done by BNRC, the Company shall pay to BNRC 7.5% of any consideration received from such deal with that company and 100,000 common shares.

On November 12, 2015, the Company announced it has entered into an agreement to replace the previously announced Master Distribution Agreement (See News Release May 28, 2015). Under the terms of the new agreement the Company will acquire the rights to distribute the next generation of disposable vaporizers to the market under the Wildflower brand. Under the original agreement the Company was to distribute the Alcura line of CBD vaporizers. This new agreement allows the Company to produce, market and distribute a Wildflowerbranded line of CBD blends to be used with our new vaporizing technology throughout the majority of the US market.

The CBD and THC products will be made available to all I-502 cannabis retailers (Washington State) through an agreement with a Washington State processor. Currently there are approximately 200 I-502 retailers. On October 12th, 2015 Washington State re-opened the licensing process to allow for additional retailers under I-502 regulations. All cannabis sales will now fall under the responsibility of the Washington State Liquor and Cannabis Board. Spokesperson for the Board, Brian Smith was quoted as saying the number of new licenses his agency can grant is open-ended. There is approximately 800 medical dispensaries facing closure but Mr. Smith stated that approximately 400 will be eligible for new licensing under I-502 regulations. With the majority of these medical dispensaries operating in the Greater Seattle Area and soon having to sell only product from I-502 processors, we believe there is still incredible growth for the industry in Washington State.

The Company has prepared a comprehensive on-line marketing campaign for its CBD vaporizer. The CBD blends are derived from industrial hemp with negligible THC content and can be sold on-line legally in most US States. The CBD vaporizer to be launched in I-502 retail outlets will be a slight variation of the online version containing marginally more THC. Other distribution targets include 4,600 Natural and Health Food stores, 800 Vitamin and Supplements outlets as well as Pharmacies and retail stores throughout Washington State.

  1. Provide a general overview and discussion of the activities of management.

Please see item 1 above.

  1. Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or oil and gas or other reports required under Ontario securities law.

Please see item 1 above.

  1. Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production programs that have been amended or abandoned.

Not applicable.

  1. Describe any new business relationships entered into between the Issuer, the Issuer’s affiliates or third parties including contracts to supply products or services, joint venture agreements and licensing agreements etc. State whether the relationship is with a Related Person of the Issuer and provide details of the relationship.

Please see item 1 above.

  1. Describe the expiry or termination of any contracts or agreements between the Issuer, the Issuer’s affiliates or third parties or cancellation of any financing arrangements that have been previously announced.

Not applicable.

  1. Describe any acquisitions by the Issuer or dispositions of the Issuer’s assets that occurred during the preceding month. Provide details of the nature of the assets acquired or disposed of and provide details of the consideration paid or payable together with a schedule of payments if applicable, and of any valuation. State how the consideration was determined and whether the acquisition was from or the disposition was to a Related Person of the Issuer and provide details of the relationship.

None.

  1. Describe the acquisition of new customers or loss of customers.

Please see item 1 above.

  1. Describe any new developments or effects on intangible products such as brand names, circulation lists, copyrights, franchises, licenses, patents, software, subscription lists and trade-marks.

None.

  1. Report on any employee hirings, terminations or lay-offs with details of anticipated length of lay-offs.

None.

  1. Report on any labour disputes and resolutions of those disputes if applicable.

None.

  1. Describe and provide details of legal proceedings to which the Issuer became a party, including the name of the court or agency, the date instituted, the principal parties to the proceedings, the nature of the claim, the amount claimed, if any, if the proceedings are being contested, and the present status of the proceedings.

Not applicable.

  1. Provide details of any indebtedness incurred or repaid by the Issuer together with the terms of such indebtedness.

During the past month, the Issuerdid not borrow any funds. However, the Issuer in its normal course of business activities, may accumulate indebtedness from time to time in the form of fees for services and management fees, as is regularly reported in the Issuer’s financial statements. The indebtedness created by the accumulation of service and management fees or any type of indebtedness can be settled with the completion of a financing, loan, or with the benefits of a successful business transaction.

Provide details of any securities issued and options or warrants granted.

Security / Number Issued / Details of Issuance / Use of Proceeds(1)
Common Shares / 2,413,000 / Exercise of warrants / $361,950 working capital

1)State aggregate proceeds and intended allocation of proceeds.

  1. Provide details of any loans to or by Related Persons.

None.

  1. Provide details of any changes in directors, officers or committee members.

None.

  1. Discuss any trends which are likely to impact the Issuer including trends in the Issuer’s market(s) or political/regulatory trends.

The Issuer is not aware of any trends that manifested themselves in the past month and have an impact on its business or markets, other than general market volatility and political trends as they relate to the regulation of marijuana.

Certificate Of Compliance

The undersigned hereby certifies that:

  1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance.
  2. As of the date hereof there were is no material information concerning the Issuer which has not been publicly disclosed.
  3. The undersigned hereby certifies to CNSX that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all CNSX Requirements (as defined in CNSX Policy 1).
  4. All of the information in this Form 7 Monthly Progress Report is true.

Dated: March 1, 2017.

William MacLean
Name of Director or Senior Officer

“William MacLean”
Signature

Director

Issuer Details
Name of Issuer
Wildflower Marijuana Inc. / For Month End
February 28, 2017 / Date of Report
YY/MM/DD
17/03/01
Issuer Address: 400- 1505 West 2nd Avenue
City/Province/Postal Code
Vancouver, British Columbia, V6B 1N2 / Issuer Fax No. / Issuer Telephone No.
(604) 559-0420
Contact Name
William MacLean / Contact Position
CEO / Contact Telephone No.
(604) 559-0420
Contact Email Address
/ Web Site Address

FORM 7 – MONTHLY PROGRESS REPORT

March 1, 2017

Page 1